Injective and BDACS plan KRW1 settlement for tokenized assets

Injective and South Korean digital-asset firm BDACS have signed a memorandum of understanding to make KRW1 a settlement asset for tokenized real-world assets on Injective, opening a route for those markets to settle in won instead of dollars. The Injective announcement says the partners will develop won-denominated settlement for real-world asset and tokenization use cases; The Block’s report says the agreement is an MOU, not a completed launch.

The steps are straightforward: BDACS issues KRW1, a stablecoin backed one-for-one by Korean won; tokenized assets on Injective can then be priced, traded and settled using that token. In principle, that lets a won-denominated transaction stay in won onchain rather than passing through a dollar stablecoin and adding currency conversion to the process.

What role would KRW1 play in an asset trade?

KRW1 would serve as the payment leg for tokenized assets: the digital representation of an asset changes hands, and KRW1 moves to settle the transaction. Injective says the collaboration is intended to let these assets trade and settle directly in won. Think of KRW1 as the cash drawer at the point of sale: the asset is what changes hands, while the stablecoin provides the payment.

That could matter for Korean institutions and investors who want to use tokenized markets without settling in dollars. Injective says assets issued through its Injective Mint system can carry holder, jurisdiction and transfer controls at the protocol level. Those controls can be configured to an issuer’s requirements, according to the company.

When can institutions mint or redeem KRW1?

BDACS says KRW1 is fully backed one-for-one by won reserves. Injective’s announcement says minting and redemption will be available to approved institutional partners, subject to regulatory approval. The agreement does not announce a date for trading to begin, name specific assets that will settle in KRW1, or say that the planned markets are already live.

The distinction matters because an MOU sets out an area for cooperation, while the settlement process still depends on implementation, institutional participation and regulatory approval. Injective says the companies will work with Korean financial institutions to bring assets onchain and expects to provide updates as specific use cases go live.

What changed is that Injective and BDACS have agreed to develop KRW1 as a won settlement option for tokenized assets on the network. The next concrete markers are approval for institutional minting and redemption, details of the first assets, and confirmation that a KRW1-settled market has gone live.

References

• Injective announcement — injective.com
• The Block’s report — theblock.co